InterventionsHuman trial
Effects of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids in Subjects with Obesity or Overweight
ADA Scientific Sessions 2025 Abstract
The paper
SUSCHAK JJ, LUCCA ANDRADE M, GEORGES B et al.
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Oral 228-OR